Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback

Oct.09
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.

Key Points

  • Imperial Brands expects double-digit FY26 NGP net revenue growth, with share gains across heated tobacco, vape and modern oral.
  • The company highlighted Pulze 3.0 and new iD sticks in heated tobacco, the blu kit range in vape, and Zone and Skruf in modern oral.
  • Acquisitions of Black Buffalo in the U.S. and Helwit in Sweden have expanded Imperial Brands' modern oral portfolio.
  • Tobacco net revenue is expected to grow at a low-single-digit rate for a sixth consecutive year, despite a low-single-digit decline in Group tobacco volumes.
  • FY26 Group adjusted operating profit is expected to rise 3% to 5%, with high-single-digit adjusted EPS growth and free cash flow above £2.2 billion.
  • Imperial Brands has completed its £1.45 billion FY26 buyback and announced a £1.5 billion FY27 programme. Its issued share capital has fallen by more than 21% since buybacks began in October 2022.

2Firsts

October 9, 2026

According to Imperial Brands' pre-close trading update released on October 8, the company expects double-digit FY26 net revenue growth from next-generation products, with market share gains across all three NGP categories: heated tobacco, vape and modern oral. Tobacco net revenue is expected to post low-single-digit growth for a sixth consecutive year. Imperial Brands also announced a £1.5 billion share buyback for FY27. Unless otherwise stated, the company's growth rates are presented at constant currency.

Imperial Brands reaffirmed guidance for 3% to 5% growth in Group adjusted operating profit, high-single-digit adjusted earnings-per-share growth and more than £2.2 billion of free cash flow for FY26. Full-year results for the period ended September 30 will be released on November 17.

NGP Revenue Seen Growing Double Digits With Share Gains Across All Three Categories

Imperial Brands expects double-digit NGP net revenue growth for FY26 and market share gains across each of its three NGP categories.

In heated tobacco, the company cited momentum from Pulze 3.0 and new iD sticks. In vape, it said the blu kit range continued to perform well. Its modern oral portfolio includes Zone and Skruf and has been expanded through the acquisitions of Black Buffalo in the U.S. and Helwit in Sweden.

Imperial Brands reported NGP net revenue growth of 7.5% in the first half of FY26, including increases of 15.3% in Europe and 60.0% in the Asia, Africa, Australasia and Central & Eastern Europe region, with share gains in all three NGP categories. Its October update continues to forecast double-digit NGP net revenue growth for the full year.

Tobacco Net Revenue Set for Sixth Consecutive Year of Growth as Volumes Decline

Imperial Brands expects tobacco net revenue to grow at a low-single-digit rate in FY26, driven by robust pricing and share gains in target segments in the U.S. and Germany. Group tobacco volumes are expected to decline at a low-single-digit rate.

The expected increase would mark a sixth consecutive year of tobacco net revenue growth, rather than volume growth.

In the first half of FY26, tobacco net revenue increased 1.5%, with the company saying pricing more than offset volume declines.

Free Cash Flow Seen Above £2.2 Billion as FY27 Buyback Rises to £1.5 Billion

Imperial Brands has completed the £1.45 billion FY26 share repurchase programme announced in October 2025.

It has now announced a further £1.5 billion buyback for FY27, which it expects to complete no later than October 29, 2027.

The company's annual buyback programmes have increased over the past three fiscal years:

Fiscal YearShare Buyback
FY25£1.25 billion
FY26£1.45 billion
FY27£1.50 billion

Imperial Brands completed the £1.25 billion FY25 programme and generated £2.7 billion of free cash flow that year.

From FY21 through FY26, Imperial Brands said it returned close to £13 billion to shareholders through dividends and share repurchases. Its issued share capital has been reduced by more than 21% since the buyback programme began in October 2022.

The company expects FY26 free cash flow of more than £2.2 billion and year-end leverage at the lower end of its 2.0-2.5 times net debt-to-EBITDA range.

Adjusted Operating Profit Seen Up 3%-5% as 2030 Savings Target Remains at £320 Million

Imperial Brands maintained its FY26 guidance for 3% to 5% growth in Group adjusted operating profit and high-single-digit growth in adjusted earnings per share.

Under its 2030 transformation programme, the company said it remains confident of delivering at least £320 million of annual savings by 2030. Manufacturing programmes delivered during FY26 are expected to underpin a future reduction of around £100 million in overhead costs, alongside continued investment in data and technology.

Imperial Brands will report its FY26 full-year results on November 17, 2026.

Follow 2Firsts for coverage of global tobacco, vaping, heated tobacco, modern oral and tobacco-company capital-market developments.

Cover Image: Imperial Brands


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands has agreed to acquire 100% of Swedish modern oral nicotine company Yoik Group AB for an initial SEK515 million, equivalent to about US$53.9 million, plus a deferred payment linked to performance over the next two years. Yoik owns nicotine pouch brand Helwit, which held about 3.4% of Sweden’s modern oral nicotine market over the past 12 months. Imperial says the acquisition will more than double its existing share of the Swedish market. Helwit is also sold elsewhere in the Nordics, through European online channels and in selected UK retail outlets.
Sep.08
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Holdings Limited will acquire 100% of PT Broad Far Indonesia through two wholly owned subsidiaries for approximately RMB 90 million. The Indonesian company manufactures and sells heat-not-burn tobacco sticks and provides OEM/ODM services. The sellers are part of a related-party group controlled by Huabao International Chair and controlling shareholder Zhu Linyao. PT Broad Far Indonesia generated $4.37 million in revenue and $177,000 in profit after tax in the first half of 2026, while net assets stood at about $326,000 at June-end. An independent valuer assessed the company’s equity at approximately RMB 93.06 million. Following completion, the HNB manufacturing operation will be consolidated into Huabao International.
News
Sep.29 by 2Firsts Perspectives
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
Philip Morris International's PMI Business Solutions Philippines has expanded its global business services hub in Makati and plans to add more than 80 positions. Established in 2021 primarily to provide finance and IT support to about 20 markets, the center now employs 519 professionals delivering roughly 600 services across 160 markets. Its functions now span finance, human resources, IT, commercial operations, data analytics, supply chain and project management. PMI says the hub's next phase will focus on AI-enabled and higher-value work. The company did not disclose the size or investment cost of the expansion.
Sep.24
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-listed consumer goods group Supreme plc says it continues to expect FY27 trading to meet market expectations as the Vaping Products Duty takes effect on October 1, while maintaining a comparatively positive view of the new tax and compliance regime. Supreme has said the framework could increase compliance complexity for smaller operators and contribute to market consolidation, while its manufacturing, compliance and distribution scale may allow it to gain share. Its 88Vape brand will retain its value positioning.
Sep.18
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08